LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 58.15 | 27.76 | 5622 | 5906 | 0.9518 | 0.9873 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 59.85 | 27.76 | 9 | 6062 | 0.0015 | -0.1349 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 59.85 | 27.76 | 5310 | 6062 | 0.8759 | 0.9662 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 59.85 | 27.76 | 595 | 6062 | 0.0981 | 0.4835 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 59.85 | 27.76 | 5828 | 6062 | 0.9613 | 0.9899 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 61.56 | 27.76 | 11 | 6217 | 0.0018 | -0.1118 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 61.56 | 27.76 | 5499 | 6217 | 0.8845 | 0.9688 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 61.56 | 27.76 | 595 | 6217 | 0.0957 | 0.4808 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 61.56 | 27.76 | 6085 | 6217 | 0.9787 | 0.9945 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 63.26 | 27.76 | 11 | 6465 | 0.0017 | -0.1111 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 63.26 | 27.76 | 5716 | 6465 | 0.8841 | 0.9689 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 63.26 | 27.76 | 663 | 6465 | 0.1025 | 0.4971 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 63.26 | 27.76 | 6399 | 6465 | 0.9897 | 0.9974 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 64.97 | 27.76 | 8 | 6656 | 0.0012 | -0.1456 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 64.97 | 27.76 | 5823 | 6656 | 0.8748 | 0.9664 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 64.97 | 27.76 | 649 | 6656 | 0.0975 | 0.4899 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 64.97 | 27.76 | 6647 | 6656 | 0.9985 | 0.9996 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 66.67 | 27.76 | 8 | 6695 | 0.0012 | -0.1455 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 66.67 | 27.76 | 6121 | 6695 | 0.9142 | 0.9775 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 66.67 | 27.76 | 752 | 6695 | 0.1123 | 0.5172 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 66.67 | 27.76 | 6929 | 6695 | 1.0348 | 1.0087 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 68.37 | 27.76 | 9 | 6879 | 0.0013 | -0.1321 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 68.37 | 27.76 | 6157 | 6879 | 0.8950 | 0.9723 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 68.37 | 27.76 | 738 | 6879 | 0.1073 | 0.5105 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 68.37 | 27.76 | 7159 | 6879 | 1.0407 | 1.0101 | MN20160318_Q01 | G16 |